## Correct Answer: B. E.coli E. coli is the most common organism causing acute bacterial prostatitis, accounting for 80–90% of cases in clinical practice. The pathophysiology involves retrograde ascent of gram-negative bacteria from the urethra and bladder, particularly in the setting of urinary tract obstruction, instrumentation (catheterization, cystoscopy), or impaired urinary flow. E. coli possesses virulence factors including P fimbriae and lipopolysaccharide (LPS) that facilitate adherence to uroepithelial cells and trigger acute inflammation. In Indian clinical settings, E. coli remains the predominant pathogen in both community-acquired and nosocomial prostatitis, especially in patients with benign prostatic hyperplasia (BPH) or urinary retention—conditions highly prevalent in the Indian male population. The organism is typically susceptible to fluoroquinolones (levofloxacin, ciprofloxacin), which are the first-line agents recommended by Indian urological guidelines for acute bacterial prostatitis due to excellent prostatic tissue penetration. Culture of expressed prostatic secretion (EPS) or post-massage urine typically yields E. coli in the majority of cases. ## Why the other options are wrong **A. Proteus** — Proteus is a gram-negative rod that causes prostatitis but is far less common than E. coli, accounting for only 5–10% of cases. It is typically associated with chronic prostatitis or recurrent UTIs with struvite stone formation (due to urease production), not acute bacterial prostatitis. NBE may include Proteus to test whether students confuse it with its role in chronic/recurrent infections. **C. Enterococcus** — Enterococcus is a gram-positive coccus that is rarely a primary pathogen in acute bacterial prostatitis; it is more commonly isolated in chronic prostatitis or as a secondary/nosocomial pathogen. It lacks the virulence factors (P fimbriae, LPS) that E. coli possesses for acute uroepithelial invasion. The trap here is confusing enterococcal UTI with enterococcal prostatitis—they are epidemiologically distinct. **D. Streptococcus Agalactiae** — Streptococcus agalactiae (Group B Streptococcus) is a gram-positive coccus that is not a typical cause of acute bacterial prostatitis in adult males. It is clinically significant in neonatal sepsis and maternal UTI but plays no role in prostatitis. Including this option tests whether students conflate GBS with gram-negative uropathogens or confuse it with other streptococcal species. ## High-Yield Facts - **E. coli causes 80–90% of acute bacterial prostatitis** via retrograde ascent from the urethra; P fimbriae and LPS are key virulence factors. - **Fluoroquinolones (levofloxacin, ciprofloxacin) are first-line DOC** for acute bacterial prostatitis in India due to excellent prostatic penetration and E. coli susceptibility. - **Risk factors for acute bacterial prostatitis include BPH, urinary retention, catheterization, and cystoscopy**—all common in Indian male population. - **Proteus and Klebsiella are secondary pathogens** in chronic/recurrent prostatitis; Enterococcus is rare in acute disease. - **Diagnosis: elevated WBC in EPS, positive urine culture post-massage, and fever + dysuria + perineal pain** are classic acute presentation. ## Mnemonics **ECOLI for Acute Prostatitis** E = **E. coli (80–90%)**; C = **Catheterization** (risk factor); O = **Obstruction** (BPH); L = **Levofloxacin** (DOC); I = **Instrumentation** (cystoscopy). Use this to anchor E. coli as the dominant pathogen and recall its risk factors and treatment in one phrase. **Gram-Negative Uropathogens Rule Acute Prostatitis** **E. coli > Proteus > Klebsiella** in acute disease (gram-negatives dominate). Gram-positives (Enterococcus, Streptococcus) are rare in acute prostatitis—they appear in chronic or mixed infections. Memory hook: 'Acute = Gram-negative; Chronic = Mixed.' ## NBE Trap NBE pairs Proteus with prostatitis to exploit students who recall its role in chronic/recurrent UTI with struvite stones and mistakenly elevate it to the most common acute pathogen. The trap conflates chronic and acute disease epidemiology. ## Clinical Pearl In Indian urology practice, a 65-year-old man with BPH presenting with acute fever, dysuria, and perineal pain almost always has E. coli prostatitis; empiric fluoroquinolone therapy (levofloxacin 500 mg BD) is started immediately without awaiting culture, as delay risks sepsis. Catheterization for retention is the single most common precipitant in this demographic. _Reference: Bailey & Love Ch. 72 (Prostate); Harrison Ch. 304 (Urinary Tract Infections); KD Tripathi Ch. 48 (Fluoroquinolones)_
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.